Do you want to read an article? Please log in or register.
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
Further Publications
![](https://cdn.healthbook.network/wp-content/uploads/2018/03/like_hb.png)